Biorepository Services Market Size and Share Analysis - Growth Trends and Forecasts (2025-2032)

Market Size and Trends

The Biorepository Services market is estimated to be valued at USD 4.8 billion in 2025 and is expected to reach USD 9.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 10.4% from 2025 to 2032. This robust growth reflects increasing demand for high-quality sample storage and management solutions across pharmaceutical, biotechnology, and healthcare sectors, supported by advancements in personalized medicine and large-scale clinical research initiatives.

Market trends indicate a growing emphasis on automation and digitalization within biorepositories to enhance efficiency, data accuracy, and sample traceability. Additionally, the integration of cloud-based platforms for real-time data access, along with stringent regulatory compliance and increasing adoption of biobanking in emerging economies, are driving market expansion. Furthermore, the rise in collaborative research efforts and the need for sustainable storage solutions are shaping the future trajectory of the biorepository services industry.

Segmental Analysis:

By Sample Type: Dominance of Blood/Plasma Driven by Clinical and Research Applications

In terms of By Sample Type, Blood/Plasma contributes the highest share of the market owing to its critical role in clinical diagnostics, therapeutic monitoring, and biomedical research. Blood and plasma samples are fundamental to a broad spectrum of analyses due to their rich content of biomarkers, proteins, and cells that provide vital insights into disease progression and treatment efficacy. The versatility of blood/plasma samples allows biorepositories to cater to multiple applications across personalized medicine, drug development, and epidemiological studies. Additionally, the relative ease of collection and standardized protocols for processing and storage increase their appeal by ensuring sample integrity and reproducibility in downstream assays. Growing focus on liquid biopsies and minimally invasive diagnostic techniques further fuels demand for biorepositories specializing in blood/plasma storage. Furthermore, advances in omics technologies, such as proteomics and metabolomics, have amplified the need for high-quality biofluid samples to uncover novel biomarkers and therapeutic targets. Collectively, these factors make blood/plasma the most sought-after sample type in biorepository services, given its high translational value and applicability across diverse biomedical fields.

By Storage Type: Cryogenic Storage as the Backbone of Long-term Sample Integrity

Cryogenic Storage contributes the highest share of the market, primarily because it ensures long-term preservation of biological samples with minimal molecular degradation. Many key specimen types, including cellular components and nucleic acids derived from blood, tissue, and other biofluids, require ultra-low temperature environments to maintain viability and molecular integrity over extended periods. Cryogenic storage techniques typically utilize temperatures near or below -150°C, often employing liquid nitrogen or mechanical freezers, which effectively halt biochemical activities and enzymatic degradation processes. This capability is indispensable for supporting longitudinal studies, biobanking initiatives, and clinical trials demanding repeated access to high-quality specimens. Additionally, advancements in cryopreservation protocols and automation technologies have improved sample handling efficiency and reduced contamination risks, further elevating the popularity of cryogenic storage. The growing adoption of regenerative medicine, stem cell research, and biopharmaceutical development also reinforces the need for cryogenic storage infrastructure to manage sensitive sample types. As a result, this segment dominates biorepository services by offering unmatched sample preservation standards essential for maintaining research validity and supporting complex therapeutic developments.

By End-User: Pharmaceutical & Biotechnology Companies Lead Due to R&D and Drug Development Demand

Pharmaceutical & Biotechnology Companies contribute the highest share of the biorepository services market, driven by their intense research and development pipelines and stringent regulatory requirements for high-quality sample management. These organizations have a continuous demand for well-characterized biological specimens to facilitate drug discovery, biomarker validation, toxicology studies, and clinical trial support. The use of biorepository services enables pharmaceutical and biotech firms to access diverse and standardized samples that accelerate translational research and innovation in therapies across therapeutic areas including oncology, immunology, and rare diseases. Moreover, the collaboration between these companies and biorepositories strengthens data integrity and compliance with global standards related to sample traceability, storage, and ethical sourcing. The increasing emphasis on personalized medicine and targeted treatments further magnifies the need for comprehensive biobanking to supply biospecimens that represent diverse patient populations. Pharmaceutical and biotechnology sectors also benefit from advanced biorepository capabilities such as integrated data management systems and secure sample tracking, which enhance operational efficiency and reduce time-to-market for new drugs. Consequently, their pivotal role as end-users underpins the growth and strategic importance of biorepository services within the life sciences ecosystem.

Regional Insights:

Dominating Region: North America

In North America, the dominance in the Biorepository Services market is driven by a well-established ecosystem comprising advanced healthcare infrastructure, robust biotechnology and pharmaceutical industries, and strong government support for biomedical research. The U.S. and Canada benefit from significant investments in precision medicine, genomics, and personalized healthcare, which require extensive biobanking capabilities. Government initiatives such as the NIH's emphasis on biorepository development and favorable regulatory frameworks facilitate growth and innovation. Prominent companies like Thermo Fisher Scientific, BioStorage Technologies, and Brooks Life Sciences contribute significantly by offering comprehensive biobanking solutions, ranging from sample storage to data management and logistics, strengthening North America's leadership position.

Fastest-Growing Region: Asia Pacific

Meanwhile, the Asia Pacific exhibits the fastest growth in Biorepository Services, propelled by expanding healthcare infrastructure, rising research activities, and increasing government funding. Countries such as China, Japan, South Korea, and India are investing heavily in biotechnology, cancer research, and genomic studies, fueling the demand for sophisticated biobanking services. Evolving trade dynamics and collaborations between public and private sectors have enhanced capabilities and accessibility to cutting-edge technologies. Notable players like CloudLIMS in India, China's BGI Group, and Japan's Nippon Gene are accelerating the market by introducing innovative storage and data management platforms tailored to regional needs, in addition to fostering international partnerships for sample sharing and research collaboration.

Biorepository Services Market Outlook for Key Countries

United States

The United States' market is characterized by a high concentration of biorepositories affiliated with leading research institutions, hospitals, and pharmaceutical companies. The U.S. government invests substantially in biobanking infrastructure through programs such as the All of Us Research Program, facilitating large-scale human health studies. Companies like Thermo Fisher Scientific and Brooks Life Sciences provide comprehensive storage, processing, and data management solutions, while fostering partnerships that accelerate translational research and clinical trials. This synergy enhances the robustness of the biorepository ecosystem and cements the country's dominant position.

China

China's market is rapidly evolving due to escalating government focus on biotechnology and precision medicine, coupled with growing domestic biobank initiatives. The Chinese government's Five-Year Plans emphasize biobanking as a critical component of national scientific development. Companies such as BGI Group and WuXi AppTec have developed extensive biorepository capabilities that support genomics research and pharmaceutical development. Cross-border collaborations and investments in advanced storage technologies are further boosting market prospects and enabling China to become a key player in biorepository services in the Asia Pacific region.

Germany

Germany continues to lead Europe's Biorepository Services market thanks to its strong biomedical research infrastructure, presence of leading pharmaceutical companies, and regulatory frameworks that promote data privacy and ethical biobanking. The country hosts renowned institutions like the German Cancer Research Center (DKFZ), which operate large-scale biobanks supporting oncology and rare disease research. Companies such as Qiagen and Cryoport provide state-of-the-art cryopreservation and logistics solutions, facilitating sample integrity and accessibility across research networks throughout Europe.

Japan

Japan's market is driven by a rapidly aging population and a strong focus on regenerative medicine and personalized healthcare. Government initiatives encouraging innovation in life sciences align with the development of extensive biobanking networks that support disease-specific research and clinical trials. Organizations such as the National Cancer Center and companies like Nippon Gene contribute significantly through their advanced storage technologies and data management platforms, promoting reliable and efficient biorepository services to meet rising demand.

Brazil

Brazil's market is gaining traction backed by increasing investments in healthcare infrastructure, academic research, and public health initiatives targeting infectious and chronic diseases. The Brazilian government supports the establishment of biorepositories to enhance population health studies and drug development locally. Local players and multinational companies collaborate to enhance biobanking capabilities, focusing on sample collection from diverse genetic pools and improving logistics across Brazil's vast geography. This growing ecosystem is positioning Brazil as a prominent player in Latin America's biorepository services landscape.

Market Report Scope

Market Segmentation

Sample Type Insights (Revenue, USD, 2020 - 2032)

• Blood/Plasma
• Tissue Samples
• Urine
• DNA/RNA
• Others

Storage Type Insights (Revenue, USD, 2020 - 2032)

• Cryogenic Storage
• Refrigerated Storage
• Room Temperature Storage
• Others

End-user Insights (Revenue, USD, 2020 - 2032)

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Hospitals & Clinics
• Contract Research Organizations (CROs)
• Others

Regional Insights (Revenue, USD, 2020 - 2032)

• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa

Key Players Insights

• STEMCELL Technologies
• Brooks Life Sciences
• Thermo Fisher Scientific
• BioStorage Technologies
• Avantor, Inc.
• Cryoport, Inc.
• Guardant Health
• Biorep Technologies
• BioCision
• Almac Group
• Eurofins Scientific
• LabCorp
• Rentschler Biopharma SE
• Q2 Solutions
• WuXi AppTec
• Covance Inc.